Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 416 | 3 | MITOCHONDRIA//ARGINASE//NADPH OXIDASE | 30587 |
| 1440 | 2 | VDAC//WARBURG EFFECT//LONIDAMINE | 8119 |
| 25264 | 1 | LONIDAMINE//IONIDAMINE//TUMOR ACIDIFICATION | 309 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | LONIDAMINE | authKW | 7616440 | 31% | 77% | 97 |
| 2 | IONIDAMINE | authKW | 271986 | 1% | 67% | 4 |
| 3 | TUMOR ACIDIFICATION | authKW | 233129 | 1% | 57% | 4 |
| 4 | ADVANCED BREAST CANCER CHEMOTHERAPY | authKW | 203991 | 1% | 100% | 2 |
| 5 | ANTISPERMATOGENIC DRUGS | authKW | 203991 | 1% | 100% | 2 |
| 6 | LONIDAMINE AND BREAST CANCER | authKW | 203991 | 1% | 100% | 2 |
| 7 | LONIDAMINE THERAPY | authKW | 203991 | 1% | 100% | 2 |
| 8 | MALE PUBERTAL MICE | authKW | 203991 | 1% | 100% | 2 |
| 9 | MITOMYCIN C DRUG COMBINATION | authKW | 203991 | 1% | 100% | 2 |
| 10 | PENN SUPERFUND TRAINING PROGRAM | address | 203991 | 1% | 100% | 2 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 4819 | 64% | 0% | 198 |
| 2 | Pharmacology & Pharmacy | 163 | 16% | 0% | 48 |
| 3 | Pathology | 82 | 5% | 0% | 16 |
| 4 | Radiology, Nuclear Medicine & Medical Imaging | 31 | 5% | 0% | 16 |
| 5 | Biophysics | 14 | 4% | 0% | 11 |
| 6 | Reproductive Biology | 13 | 2% | 0% | 5 |
| 7 | Chemistry, Medicinal | 11 | 3% | 0% | 8 |
| 8 | Microscopy | 8 | 1% | 0% | 2 |
| 9 | Obstetrics & Gynecology | 7 | 2% | 0% | 7 |
| 10 | Andrology | 6 | 0% | 0% | 1 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | PENN SUPERFUND TRAINING PROGRAM | 203991 | 1% | 100% | 2 |
| 2 | DIPARTIMENTO MED SPERIMENTALE SANITA PUBBLICA | 101996 | 0% | 100% | 1 |
| 3 | EXCELLENCE ENVIRONM TOXICOL MED | 101996 | 0% | 100% | 1 |
| 4 | INVEST BIOENERGET CIBIERG | 101996 | 0% | 100% | 1 |
| 5 | IST CLIN MED IV | 101996 | 0% | 100% | 1 |
| 6 | IST ISTOL EMBRIOL LARGO FRANCESCO VITO 1 | 101996 | 0% | 100% | 1 |
| 7 | ULTRASTRUCT VIALE REGINA ELENA 299 | 101996 | 0% | 100% | 1 |
| 8 | INTERDISCIPLINARY MALE CONTRACEPT DRUG | 67994 | 1% | 33% | 2 |
| 9 | ASL6 | 50997 | 0% | 50% | 1 |
| 10 | HUMAN BIOPATHOL HAEMATOL | 50997 | 0% | 50% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ONCOLOGY | 11257 | 7% | 1% | 21 |
| 2 | EXPERIMENTAL AND MOLECULAR PATHOLOGY | 7319 | 5% | 1% | 14 |
| 3 | CHEMOTHERAPY | 3972 | 3% | 0% | 10 |
| 4 | TUMORI | 3631 | 4% | 0% | 13 |
| 5 | ANTICANCER RESEARCH | 3258 | 8% | 0% | 25 |
| 6 | INTERNATIONAL JOURNAL OF ONCOLOGY | 3004 | 6% | 0% | 17 |
| 7 | SEMINARS IN ONCOLOGY | 2804 | 4% | 0% | 12 |
| 8 | INTERNATIONAL JOURNAL OF HYPERTHERMIA | 1261 | 2% | 0% | 5 |
| 9 | ONCOLOGY RESEARCH | 1256 | 1% | 0% | 4 |
| 10 | CANCER BIOTHERAPY | 1072 | 0% | 1% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |